FDA authorises restart of the COVID-19 AZD1222 vaccine US phase 3 trial

This article was originally published here

The Food and Drug Administration (FDA) today authorised the restart in the US, following the resumption of trials in other countries in recent weeks. The FDA reviewed all

The post FDA authorises restart of the COVID-19 AZD1222 vaccine US phase 3 trial appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply